Kids' painkiller study aims for safer dosing

NCT ID NCT02044497

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how children aged 0-6 process the painkiller oxycodone after surgery. Researchers will measure drug levels in the blood and check certain genes that affect how the drug is broken down. The goal is to understand why some children may have more side effects or need different doses. About 68 children having specific surgeries will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

oral oxycodone

What this could lead to

If successful, this could help doctors give safer, more effective pain relief to children after surgery by tailoring doses based on genetics.

What could go wrong

This is a small, single-center study that only observes drug levels and genetics—it won't directly change treatment yet. Results may not apply to all children or surgeries.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC SURGICAL PATIENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Children Hospital

    Boston, Massachusetts, 02115, United States